Cardinal Health's Michelle Britt discusses the policy changes needed to secure independent pharmacy's future, from state advocacy wins to giving pharmacists a seat at the table. Independent pharmacies ...
TrumpRx passed its six-month mark with more than 800 listed products and a new commitment from 10 pharmacy benefit managers to surface its cash prices at the point of prescribing.
As specialty therapies become more complex, research continues to show that educational, emotional, and practical barriers can influence whether patients initiate therapy and remain engaged over time.
Similar activation models can strengthen trial recruitment, precision medicine, and population health by converting data into ...
AMCP's Adam Colborn discusses survey findings on TrumpRx's six-month performance, examining payer skepticism about pricing ...
Cardinal Health's Michelle Britt discusses how independent pharmacies are expanding clinical services and leaning on ...
Pharmaceutical Commerce's conversation with Vikram Anand, president of compliance services at EVERSANA, on pharmacovigilance (PV) infrastructure closes with a look at what connect ...
EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...
Ten PBMs will integrate TrumpRx cash pricing into RTBT displays, allowing prescribers and patients to compare cash-pay versus plan benefit costs at the point of prescribing. Clinician workflow remains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results